Nulibry Europska Unija - islandski - EMA (European Medicines Agency)

nulibry

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Sugammadex Amomed Europska Unija - islandski - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Nicorette Cooldrops Hörð munnsogstafla 2 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

nicorette cooldrops hörð munnsogstafla 2 mg

mcneil denmark aps - nicotinum resin-komplex - hörð munnsogstafla - 2 mg

Dronedarone STADA (Verodron) Filmuhúðuð tafla 400 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

dronedarone stada (verodron) filmuhúðuð tafla 400 mg

stada arzneimittel ag - dronedaronum hýdróklóríð - filmuhúðuð tafla - 400 mg

Nicorette Cooldrops Hörð munnsogstafla 4 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

nicorette cooldrops hörð munnsogstafla 4 mg

mcneil denmark aps - nicotinum resin-komplex - hörð munnsogstafla - 4 mg

Pombiliti Europska Unija - islandski - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).